ANTITRUST: Formula for Controversy

ANTITRUST: Formula for Controversy

When most people gaze at a newborn child, they see a bundle of joy. The makers of infant formula see something else: a bundle of loot. That's the argument of industry critics who claim that the leaders of the $1.5 billion formula business have unfairly boosted their prices 150% during the 1980s. Last week the state of Florida filed a lawsuit in federal court against the top U.S. formula makers: Abbott Laboratories (maker of Similac), American Home Products (Nursoy) and Bristol-Myers Squibb (Enfamil). The civil suit accuses the companies of fixing and inflating formula prices.

Antitrust accusations have dogged the firms...

Want the full story?

Subscribe Now

Subscribe
Subscribe

Get TIME the way you want it

  • One Week Digital Pass — $4.99
  • Monthly Pay-As-You-Go DIGITAL ACCESS$2.99
  • One Year ALL ACCESSJust $30!   Best Deal!
    Print Magazine + Digital Edition + Subscriber-only Content on TIME.com

Learn more about the benefits of being a TIME subscriber

If you are already a subscriber sign up — registration is free!